Miranda Technologies (TSX:MT) released its fiscal 2011 results. Revenue was a record $181.8 million, besting last year’s $143.6 million. Miranda CEO Strath Goodship said: “Revenues and profitability were at record levels for 2011, reflecting our success at offering innovative solutions that deliver real value to broadcasters and television service providers. The growth strategies we have […]
Archives for February 2012
Cantech Letter talks to Sensio CEO Nicholas Routhier
It’s Wednesday at 10am. Is 3D in or out fashion right now? Many techs (the cleantech space leaps to mind) would be right in asserting that their sub-sectors are cyclical. But none could hope to match the roller-coaster that is the 3D space. In 2009, right around the time that James Cameron’s Avatar was released, […]
Com Dev, International Road and Kelso Technologies: Today in Canadian Tech
Com Dev (TSX:CDV) reported that its US subsidiary added Lockheed Martin as a customer. While the first order placed by Lockheed Martin is less than $1 million, management says it allows Com Dev USA to demonstrate its capabilities to Lockheed Martin in a tangible way. The contract includes design, space qualification and production of high-power, […]
Intertainment CEO David Lucatch talks Ortsbo Spinoff
Intertainment Media (TSXV:INT) today announced the details of a plan to spin off its real-time translation offering, Ortsbo. As far back as November of last year, management said it felt Ortsbo’s growth would be accelerated as independently listed company, and that current Intertainment shareholders would benefit from the spin out should Intertainment maintain a significant […]
H20 Innovation, Destiny Media and Sandvine: Today in Canadian Tech
Valeant Pharmaceuticals (TSX:VRX) reported its fiscal 2011 results. Sales were $2. 25 bilion, nearly double 2010’s $1.13 billion. Valeant CEO J. Michael Pearson said: “Our performance continues to demonstrate the strength of our diversified model and our capacity to integrate acquisitions and still deliver strong top-line and bottom-line results.” Shares of Valeant closed today up […]
TrueContext, Agrimarine and YM Biosciences: Today in Canadian Tech
Route 1 (TSXV:ROI) announced a normal course issuer bid dated Feb. 24, 2012. The company may repurchase for cancellation, up to 35,480,904 shares of its own stock. Purchases will be made by Paradigm Capital on behalf of the company. Shares of Route 1 closed today even at $.08 cents. More… Pure Technologies (TSX:PUR) announced that […]
Four Disruptive Canadian Medical Device Juniors
Investment themes come and go. Whether it’s internet advertising sending your daily hometown newspaper under or sky high resource prices driven by Chinese demand, the stories behind the movement of money may have various life expectancies, but they all grab our attention for at least a moment. A decade ago, the plotline of an aging […]
Zecotek, Electrovaya and SXC Health: Today in Canadian Tech
Zecotek Photonics (TSXV: ZMS) announced its subsidiary, Zecotek Imaging Systems Pte Ltd., has started legal action in United States Federal District Court in Los Angeles against defendants Saint-Gobain Corporation and Philips for infringement of a Zecotek U.S. Patent. Dr. A.F. Zerrouk, CEO of Zecotek said: “We believe that this patent is fundamental, and that damages […]
M Partner’s Shuttleworth Upgrades Guestlogix from Sell to Hold
The definition of insanity, Albert Einstein famously quipped, “is doing the same thing over and over again and expecting different results”. For Toronto’s Guestlogix, the idea of moving their business up the value chain seemed like a no-brainer. After all, the company has successfully delivered ancillary revenue to airlines for a decade. In actual practice, […]
Cryptologic, SXC Health and Webtech Wireless; Today in Canadian Tech
Pivotal Therapeutics (CSNX:PVO) announced it has filed five international patent applications related to its lead product VASCAZEN. Pivotal President Rachelle MacSweeney said: “The filing of these PCT patent applications is a critical step in Pivotal’s strategy for securing global Intellectual Property rights for VASCAZEN.” Shares of Pivotal closed today down 2.2% to $.225 cents. More… […]
- 1
- 2
- 3
- …
- 5
- Next Page »